-
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
-
Minnesota’s unique Long COVID program retains funding following advocacy
-
Los Angeles’ $13M COVID-19 relief funds could go to building upgrades, not Long COVID care
-
Illinois could become the first state in the country to ban mask bans. Here’s how we created the bill to do it.
-
Secretary Kennedy promises to support Long COVID treatment research in Senate hearing, says son is “dramatically affected”
-
“Millions Missing” protest at the Capitol demands myalgic encephalomyelitis funding, social support
-
Minnesota House budget proposes eliminating state Long COVID program
Science
Covid-19
Health
-
Alice Wong, disability activist and luminary, dies at 51
-
As the American West faces increasing air pollution, protecting the right to mask is vital
-
Business school competition centers Long COVID and IACCs
-
Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used?
-
NBA player Kristaps Porziņģis shares POTS diagnosis
-
Shutdown leaves gaps in states’ health data, possibly endangering lives
-
The U.K.’s plan for ME has failed us. Members of parliament must step up.
-
Work until you disappear: Long COVID ensnared me in an exploitative health system
-
We must free Long COVID and the people living with it from the mind-body trap
-
Research ethics boards need urgent training on Long COVID and myalgic encephalomyelitis